Inhibition of cholesterol synthesis ex vivo and in vivo by fluvastatin,a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase |
| |
Authors: | A Yamamoto S Itoh K Hoshi K Ichihara |
| |
Institution: | (1) Department of Pharmacology, Hokkaido Institute of Pharmaceutical Sciences, 7-1 Katsuraoka-cho, 047-02 Otaru, Japan |
| |
Abstract: | The inhibitory effect of fluvastatin sodium (fluvastatin), a new type of 3-hydroxy-3-methylglutaryl (HMG) coenzyme A inhibitor, on de novo cholesterol synthesis was investigated and compared with that of pravastatin. Fluvastatin at a concentration of 12.5 mg/kg inhibited sterol synthesis ex vivo from 14C]acetate in rat liver and ileum by 97–99% with respect to the control, while the inhibition in kidney was 55%. The inhibition by fluvastatin in the liver and ileum persisted for approximately 9 h after administration. Significant differences between fluvastatin also had an inhibitory effect on cholesterol synthesis in vivo in various tissues of rats given 14C]acetate intraperitoneally. Sterol synthesis in the liver, ileum and kidney was inhibited by over 95% 3 h after administration of 6.25 mg/kg of fluvastatin. Significant differences between fluvastatin and pravastatin were found in the liver and ileum. Fluvastatin was more potent than pravastatin in inhibiting both ex vivo and in vivo sterol synthesis in the ileum (but not in kidney) and liver. |
| |
Keywords: | Fluvastatin hydroxymethylglutaryl-CoA reductase hydroxymethylglutaryl-CoA reductase inhibitor cholesterol synthesis rat peripheral organ |
本文献已被 SpringerLink 等数据库收录! |